- Investigator
- Mark Hudak
- Ages
- 0 Years - 1 Years
- Sexes
- All
Clinical trials
-
Central Nervous System Derived Exosomes: A Novel Source of Biomarkers for Neonatal Hypoxic Ischemic Encephalopathy -
Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures - Investigators
- Ramon E Bautista, Suparna R Krishnaiengar, Katherine A Zarroli
- Ages
- 12 Years - N/A
- Sexes
- All
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of Asapiprant in Hospitalized Adults With COVID-19 - Investigator
- Carmen Isache
- Ages
- N/A
- Sexes
- All
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
A multicenter randomized controlled trial to establish the impact of MeMed BV簧 on management of patients with suspected Lower Respiratory Tract Infections - Investigator
- Phyllis L Hendry
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
Precision Cancer Survivorship Cohort - Ages
- 18 Years - N/A
- Sexes
- All